Hologic, Inc. announced the launch of the new Hologic Global Access Initiative, in partnership with the Clinton Health Access Initiative (CHAI) and MedAccess (backed by the...
Audience: Patients with a Zoll LifeVest 4000 wearable cardioverter defibrillator Caregivers of patients with a Zoll LifeVest 4000 wearable cardioverter defibrillator Cardiologists, electrophysiologists, cardiac surgeons, primary...
The National Institutes of Health, looking to leverage cloud computing to break down barriers to accessing of large biomedical datasets and enable easier computing for researchers,...
Boston Scientific Corporation has been notified of an unsolicited mini-tender offer by TRC Capital Corporation (TRC) to purchase up to three million shares of Boston Scientific’s...
Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the second quarter ended June 30, 2018. Second quarter 2018 highlights...
The Board of Directors of BD (Becton, Dickinson and Company) has declared a quarterly dividend of USD 0.75 per common share, payable on September 28, 2018 to holders of record...
Sysmex America and Advanced Instruments announced a partnership today that will broaden the Sysmex portfolio with Advanced Instruments’ automated GloCyte cell counter system. The technology provides...
Pfizer announced it will increase its commitment to US manufacturing with a USD 465 million investment to build one of the most technically advanced sterile injectable pharmaceutical...
3M reported second-quarter 2018 results. “3M had a strong quarter, including organic growth of 6 percent that was broad-based across all business groups and geographic areas,”...
Bristol-Myers Squibb Company and Tsinghua University, have entered into a collaboration to discover therapeutic agents against novel targets for autoimmune diseases and cancers. The collaboration brings...
Waters Corporation announced second quarter 2018 sales of USD 596 million, a 7 percent increase as reported, versus sales of USD 558 million for the second...
GlaxoSmithKline plc and Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, today announced the transition of the development program for GSK3377794 (GSK ‘794),...
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced the FDA clearance of its...
Waters Corporation, Prosolia, Inc. and the Purdue Research Foundation (PRF) announced that Waters acquired exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry...
The Board of Directors of PerkinElmer, Inc., declared a regular quarterly dividend of USD 0.07 per share of common stock on July 23, 2018. This dividend...
Copyright © 2024 Medical Buyer